Home › Benign Tumors › NCT07182045

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Inclusion Criteria:

* Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
* Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids

Exclusion Criteria:

* Pregnancy,
* Age \<18yo,
* Patients undergoing concomitant surgery such as endometriosis surgery,
* Suspected malignancy

About the study

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

What is being tested

• Temporary clamping of uterine and ovarian vessels (other)

Sponsor: The University of Texas Health Science Center, Houston · Participants: 120 · Started: Sep 18, 2025

Contact the study team

• Randa Jalloul, MD · Phone: 3137128603

Official record on ClinicalTrials.gov — NCT07182045

Locations in the U.S.

Conditions

• Benign Tumors
• Bleeding

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.